Clinical trial
Study of the M1 Positive Allosteric Modulator VU0467319
NCT03220295 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the M1 Positive Allosteric Modulator VU0467319
- Lead sponsor
- Vanderbilt University
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- July 28, 2017
- Completion date
- October 30, 2019
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive impairment